To evaluate in vivo B-VEC-mediated COL7A1 gene delivery, intradermal B-VEC injections were administrated to C7-deficient mice, which closely recapitulate the RDEB skin phenotype22. The gene discussed is COL7A1; the disease is recessive dystrophic epidermolysis bullosa.